Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $1.90
10% from low
Exchange
OTC Link
CS
Borrow rate
1.98%
Moderate
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $950.0K | $568.0K | $523.0K | $1.3M | $1.2M | $1.1M | $2.1M | $250.0K |
| Gross profit | −$950.0K | −$568.0K | −$523.0K | −$1.3M | −$1.2M | −$1.1M | −$2.1M | −$250.0K |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $10.5M | $10.1M | $6.8M | $12.6M | $9.2M | $11.9M | $8.9M | $2.3M |
| Operating income | −$17.1M | −$15.6M | −$11.2M | −$18.6M | −$15.8M | −$20.6M | −$20.4M | −$9.5M |
| EBITDA | −$14.8M | −$14.5M | $35.3M | −$12.3M | −$14.6M | −$16.0M | −$23.2M | −$8.4M |
| Net income | −$19.2M | −$51.9M | $34.0M | −$13.6M | −$15.9M | −$17.1M | −$16.3M | −$8.6M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -106.91 | -238.41 | 91.90 | -18.32 | -27.59 | -18.59 | -29.32 | -10.66 |
Annual figures · source: Financial Modeling Prep
AMPIO PHARMS INC
No one on the platform currently holds AMPE.
No tracked institution reports a position in AMPE as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-09-12 | 1-for-20reverse |
| 2022-11-10 | 1-for-15reverse |
No one on the platform has traded AMPE yet.
| $1949 |
| — |
| IVBTInnovation1 Biotech Inc. | $0.00 | +0.00% | $4494 | — |
| KLDOKaleido Biosciences, Inc. | $0.00 | +0.00% | $4262 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Fundamental analysis of $AMPE (Ampio Pharmaceuticals, Inc.) based on financial data and reported results. #AMPE #Ampio
View on StockTwits ↗$MVIS giving me major AMPE vibes from the Covid era. Same story: constant "executing" talk, delays, and a sliding share price. I remember my $AMPE avg was around $1, it tanked to the .20s, then rocketed to $3+ in the same year. Walked away with 6 figures on that one before it eventually went south. 💰 Hoping lightning strikes twice here. My avg here is $1.04, not as big a position as I had in AMPE, but looking for at least a 2x to make it worth the wait. Anyone else here had money in $AMPE back in the day?
View on StockTwits ↗$AMPE lmfao i remember swinging this when i first started on the stocks
View on StockTwits ↗The one thing no one’s telling you about $AMPE. Spoiler: it might be the only thing that actually makes you thousands. https://11th.com/cases/ampio-shareholder-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=09052025_1 #Ampio #AMPE
View on StockTwits ↗$AMPE investors, if you follow us, you already knew about it. This is the good news you needed about $AMPE today. Go check it out: https://11th.com/cases/ampio-shareholder-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=08282025_1 #Ampio #AMPE
View on StockTwits ↗Losses on $AMPE aren’t the end of the story. Find out how to recover: https://11th.com/cases/ampio-shareholder-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=08202025_1 #AMPE
View on StockTwits ↗Took a hit on $AMPE? You’re not alone — and there’s a way forward. Find out how to recover: https://11th.com/cases/ampio-shareholder-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=08122025_1 #AMPE
View on StockTwits ↗$AMPE At the initial prefictions of 60 csts per affected share it was woth taking the time but at new predictions of 10 cents a share a d in that window of imez Its just not work it
View on StockTwits ↗Took a hit on $AMPE? You’re not alone — and there’s a way forward. Find out how to recover: https://11th.com/cases/ampio-shareholder-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=dailyposts&utm_content=08012025_1 #AMPE
View on StockTwits ↗$AMPE losses? There is a recovery path you can follow. Here’s where to start: https://11th.com/cases/ampio-shareholder-settlement #Ampio #AMPE
View on StockTwits ↗$AMPE agreed to a $3M settlement with investors over claims it misrepresented the efficacy of its drug Ampion. Who’s eligible? Anyone who bought and held $AMPE stock between December 29, 2020 and October 31, 2022. Do I need to sell my shares to qualify? No — you're eligible if you purchased during that period, regardless of whether you sold or still hold. How much is the payout? Estimated at $0.02 per share — but if only 25% of eligible investors file, the payout could increase to $0.08 per share. Can I still file? Yes — late claims are currently being considered, subject to court approval. When do payouts happen? Typically 8–12 months after the court grants final approval (hearing set for February 19, 2025). To file your claim: https://11th.com/cases/ampio-shareholder-settlement
View on StockTwits ↗#Ampio has agreed to a $3M settlement with $AMPE investors to resolve claims it misrepresented the effectiveness of Ampion for treating inflammatory conditions. If you bought $AMPE between December 29, 2020, and October 31, 2022, you can file a claim for payment here: https://11th.com/cases/ampio-shareholder-settlement
View on StockTwits ↗$AMPE investors, if you follow us, you already knew about it. Here’s the good news you’ve been waiting for. Go check it out. #Ampio $AMPE https://11th.com/cases/ampio-shareholder-settlement
View on StockTwits ↗Don’t forget that if you held $AMPE, there’s a significant settlement you can also claim. Consider it the dividend #Ampio never paid. https://11th.com/cases/ampio-shareholder-settlement
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.